| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Vanessa J Kumpf | |
| P2860 | cites work | Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children | Q33335068 |
| Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment | Q33694185 | ||
| AGA technical review on short bowel syndrome and intestinal transplantation | Q34187842 | ||
| Guidelines for the management of intravascular catheter-related infections | Q34219610 | ||
| Parenteral nutrition-associated cholestasis | Q34236336 | ||
| Hepatobiliary complications of total parenteral nutrition | Q34359168 | ||
| Parenteral nutrition-associated liver complications in children | Q34523863 | ||
| The use of selected nutrition supplements and complementary and alternative medicine in liver disease | Q34554574 | ||
| Prevention of parenteral nutrition-associated liver disease in children | Q34572743 | ||
| Total parenteral nutrition-associated liver disease | Q34823472 | ||
| Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction | Q35040130 | ||
| Acute acalculous cholecystitis | Q35178774 | ||
| Taurine: an essential amino acid to prevent cholestasis in neonates? | Q35653342 | ||
| Drug-induced liver disease 2004. | Q36092529 | ||
| Chronic intestinal pseudo-obstruction: assessment and management | Q36394212 | ||
| An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis | Q38242850 | ||
| Phenobarbital does not prevent total parenteral nutrition-associated cholestasis in noninfected neonates | Q39589140 | ||
| Ursodiol for hepatobiliary disorders | Q40664612 | ||
| Metronidazole prevention of serum liver enzyme abnormalities during total parenteral nutrition | Q41340365 | ||
| Liver complications of pediatric parenteral nutrition--epidemiology | Q41686406 | ||
| Plasma choline concentrations in children requiring long-term home parenteral nutrition: a case control study | Q41690215 | ||
| Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial | Q43725242 | ||
| Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition | Q44075327 | ||
| Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition | Q45016369 | ||
| Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. | Q45041398 | ||
| Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition | Q45063726 | ||
| Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome. | Q46203714 | ||
| Changes of Hepatic Morphology During Parenteral Nutrition With Lipid Emulsions Containing LCT or MCT/LCT Quantified by Ultrasound | Q46428442 | ||
| High serum phytosterol levels in short bowel patients on parenteral nutrition support. | Q46492683 | ||
| Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine | Q46656482 | ||
| Total parenteral nutrition-associated cholestasis in surgical neonates may be reversed by intravenous cholecystokinin: A preliminary report | Q51124108 | ||
| Effect of sequential erythromycin and octreotide on antroduodenal manometry. | Q51561386 | ||
| Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. | Q51608516 | ||
| Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. | Q51639364 | ||
| P433 | issue | 3 | |
| P921 | main subject | liver disease | Q929737 |
| P304 | page(s) | 279-290 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Nutrition in Clinical Practice | Q7070513 |
| P1476 | title | Parenteral nutrition-associated liver disease in adult and pediatric patients | |
| P478 | volume | 21 |
| Q38928472 | A Product Review of Alternative Oil-Based Intravenous Fat Emulsions |
| Q26865276 | Controversies in the Mechanism of Total Parenteral Nutrition Induced Pathology |
| Q42708334 | Development of liver dysfunction under artificial nutrition: a reason to modify nutrition therapy in the intensive care unit? |
| Q36480403 | Dysregulation of bile acid homeostasis in parenteral nutrition mouse model |
| Q43209843 | Early enteral nutrition in combination with parenteral nutrition in elderly patients after surgery due to gastrointestinal cancer |
| Q53645486 | Effect of an Olive Oil-Based Lipid Emulsion Compared With a Soybean Oil-Based Lipid Emulsion on Liver Chemistry and Bile Acid Composition in Preterm Infants Receiving Parenteral Nutrition: A Double-Blind, Randomized Trial. |
| Q33633700 | Glutamine-supplemented parenteral nutrition and probiotics in four adult autoimmune enteropathy patients |
| Q37007375 | Glycyrrhizin represses total parenteral nutrition-associated acute liver injury in rats by suppressing endoplasmic reticulum stress |
| Q28088482 | Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article |
| Q55399636 | Indications and complications of inpatient parenteral nutrition prescribed to children in a large tertiary referral hospital. |
| Q38929998 | Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient: Understanding the Differences. |
| Q47611244 | Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis |
| Q37674147 | Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions |
| Q47849531 | Metabolic Complications of Home Parenteral Nutrition |
| Q56020294 | Newly Identified Mechanisms of Total Parenteral Nutrition Related Liver Injury |
| Q54090957 | No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model. |
| Q37254762 | Nutrition therapy in critically ill infants and children |
| Q50189684 | Nutritional therapy complications in children with ultra-short bowel syndrome include growth deficiency but not cholestasis |
| Q92372853 | Nutritrauma: A Key Concept for Minimising the Harmful Effects of the Administration of Medical Nutrition Therapy |
| Q53525960 | Oleanolic Acid Improves Gut Atrophy Induced by Parenteral Nutrition. |
| Q38903889 | Parenteral Nutrition Basics for the Clinician Caring for the Adult Patient |
| Q90746904 | Parenteral Nutrition-Associated Liver Disease |
| Q36004900 | Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. |
| Q27026472 | Pathogenesis and treatment of parenteral nutrition-associated liver disease |
| Q50005577 | Pediatric Intestinal Failure-Associated Liver Disease: Challenges in Identifying Clinically Relevant Biomarkers |
| Q46172274 | Pharmaceutical interventions in metabolic and nutritional follow-up of surgical patients receiving parenteral nutrition |
| Q38074113 | Plasma fatty acids in premature infants with hyperbilirubinemia: before-and-after nutrition support with fish oil emulsion |
| Q50630108 | Preliminary findings of long-term neurodevelopmental outcomes of infants treated with intravenous fat emulsion reduction for the management of parenteral nutrition-associated cholestasis. |
| Q46504486 | Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid-Treated Animals Receiving Parenteral Nutrition |
| Q43524718 | Prevalence of liver complications in children receiving long-term parenteral nutrition. |
| Q36824466 | Principles and strategies for monitoring home parenteral nutrition |
| Q34979406 | Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantation. |
| Q59812053 | Risk factors of hepatic function alterations in hospitalized adult patients treated with short-term parenteral nutrition receiving the same lipid composition at the same dose |
| Q38150924 | Risks and benefits of prophylactic cyclic parenteral nutrition in surgical neonates |
| Q58696899 | Role of the Gut⁻Liver Axis in Driving Parenteral Nutrition-Associated Injury |
| Q46806743 | Serum albumin level in the management of postoperative enteric fistula for gastrointestinal cancer patients |
| Q38184285 | Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure. |
| Q37717898 | State of the art review: Intravenous fat emulsions: Current applications, safety profile, and clinical implications |
| Q90448566 | Utility of liver biopsy in the evaluation of pediatric total parenteral nutrition cholestasis |
| Q43478259 | Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludge |
Search more.